For: | Li Y, Ma FH, Xue LY, Tian YT. Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study. World J Gastroenterol 2020; 26(8): 818-827 [PMID: 32148379 DOI: 10.3748/wjg.v26.i8.818] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i8/818.htm |
Number | Citing Articles |
1 |
Manlio Monti, Martina Valgiusti, Michele Pavarana, Roberto Petrioli, Carlo Milandri. Gastric Cancer: the 25-year R-Evolution. Updates in Surgery 2022; : 93 doi: 10.1007/978-3-030-73158-8_11
|
2 |
Matthew G.K. Benesch, Alexander Mathieson. Epidemiology of Signet Ring Cell Adenocarcinomas. Cancers 2020; 12(6): 1544 doi: 10.3390/cancers12061544
|
3 |
Shen Gao, Xuan Li, Weigang Shi, Limin Huo, Huimin Liu, Wei long Zhong. Efficacy of the Low Dose Apatinib plus Chemotherapy on Advanced Gastric Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/3009494
|
4 |
Riccardo Giampieri, Maria Giuditta Baleani, Alessandro Bittoni, Francesca Rastelli, Vincenzo Catalano, Michela Del Prete, Silvia Chiorrini, Giada Pinterpe, Francesco Graziano, Francesca Chiara Giorgi, Renato Bisonni, Rosarita Silva, Paolo Alessandroni, Lara Mencarini, Rossana Berardi. Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy. Cancers 2023; 15(13): 3342 doi: 10.3390/cancers15133342
|
5 |
Yang Li, Zhikai Zhu, Fuhai Ma, Liyan Xue, Yantao Tian. <p>Gastric Signet Ring Cell Carcinoma: Current Management and Future Challenges</p>. Cancer Management and Research 2020; : 7973 doi: 10.2147/CMAR.S268032
|
6 |
Emma C. Gertsen, Arjen van der Veen, Hylke J. F. Brenkman, Lodewijk A. A. Brosens, Rachel S. van der Post, Rob H. A. Verhoeven, Josianne C. H. B. M. Luijten, Pauline A. J. Vissers, Erik Vegt, Richard van Hillegersberg, Peter D. Siersema, Jelle P. Ruurda. Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study. Annals of Surgical Oncology 2024; 31(3): 1760 doi: 10.1245/s10434-023-14690-y
|
7 |
Lauren M. Janczewski, Dhavan Shah, Amy Wells, David J. Bentrem, John D. Abad, Akhil Chawla. The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors. Journal of Surgical Oncology 2023; 127(7): 1116 doi: 10.1002/jso.27233
|
8 |
Jie Qin, Yingpeng Shi, Xueli Zheng, Ya Lan, Mingxin Zhang, Mi Liu, Shoib Baba. An Evaluation of Fluorouracil plus Paclitaxel and Oxiliplatin as a First‐Line Treatment for Advanced Gastric Squamous Cell Carcinoma. Evidence-Based Complementary and Alternative Medicine 2023; 2023(1) doi: 10.1155/2023/2176371
|
9 |
Hua-Kai Tian, Zuo Zhang, Zhi-Kun Ning, Jiang Liu, Zi-Tao Liu, Hao-Yu Huang, Zhen Zong, Hui Li. Clinicopathological characteristics and prognosis of gastric signet ring cell carcinoma. World Journal of Clinical Cases 2022; 10(29): 10451-10466 doi: 10.12998/wjcc.v10.i29.10451
|
10 |
Yongkang Lai, Junfeng Xie, Xiaojing Yin, Weiguo Lai, Jianhua Tang, Yiqi Du, Zhaoshen Li. Survival Outcome of Gastric Signet Ring Cell Carcinoma Based on the Optimal Number of Examined Lymph Nodes: A Nomogram- and Machine-Learning-Based Approach. Journal of Clinical Medicine 2023; 12(3): 1160 doi: 10.3390/jcm12031160
|
11 |
L. Charles, Archana Elangovan, Yadav Nisha, Esha Jafa, Vikram Kate, Sandhiya Selvarajan, Smita Kayal, Rajesh Nachiappa Ganesh, Biswajit Dubashi, Prasanth Penumadu, Prasanth Ganesan. Clinicopathological features and survival outcomes for gastric adenocarcinoma: Real-world single-center data. Indian Journal of Gastroenterology 2024; 43(6): 1209 doi: 10.1007/s12664-023-01455-4
|
12 |
Peng Jin, Xiaoyan Ji, Shuai Ma, Wenzhe Kang, Hao Liu, Yang Li, Fuhai Ma, Haitao Hu, Jianping Xiong, Yantao Tian. Adjuvant chemotherapy indications for stage I gastric cancer patients with negative lymph node. Clinics and Research in Hepatology and Gastroenterology 2021; 45(6): 101634 doi: 10.1016/j.clinre.2021.101634
|
13 |
Biao Hu, Run-Pu Zou, Yin-Wen Gan, Yi-Hao Zhu, Si-Min Ren, Wei-Zhong Hou, Zhi-Xin Xie, Ru Wang, Wen-Ting Yang, Peng-Ji Lin, Jun-Tao Feng, Zi-Min Gao, Xu-Guang Guo. A population-based predictive model to identify patients with signet ring cell carcinoma of the stomach who are most suitable for primary tumor resection. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02544-y
|
14 |
Wenzhe Kang, Hongmei Zeng, Jianping Xiong, Yang Li, Peng Jin, Xinxin Shao, Haitao Hu, Bingzhi Wang, Yibin Xie, Yantao Tian. Survival of patients with gastric cancer surgically treated at the National Cancer Center of China from 2011 to 2018 according to stage at diagnosis. Journal of the National Cancer Center 2022; 2(3): 132 doi: 10.1016/j.jncc.2022.07.002
|
15 |
Umberto Bracale, Francesco Corcione, Giusto Pignata, Jacopo Andreuccetti, Pasquale Dolce, Luigi Boni, Elisa Cassinotti, Stefano Olmi, Matteo Uccelli, Monica Gualtierotti, Giovanni Ferrari, Paolo De Martini, Miloš Bjelović, Dragan Gunjić, Diego Cuccurullo, Antonio Sciuto, Felice Pirozzi, Roberto Peltrini. Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi‐institutional propensity score‐matched study. Journal of Surgical Oncology 2021; 124(8): 1338 doi: 10.1002/jso.26657
|
16 |
Xiao-Xiao Shao, Xi-Chen Li, Zi-Jian Lin, Ye-Jiao Ruan, Guang-Rong Lu, Wei-Zhong Wang, He Huang. A Prognostic Model for Survival in Patients with Gastric Signet Ring Cell Carcinoma. Digestive Diseases 2024; 42(3): 221 doi: 10.1159/000536454
|
17 |
Jian-Hong Yu, Zao-Zao Wang, Ying-Chong Fan, Mao-Xing Liu, Kai Xu, Nan Zhang, Zhen-Dan Yao, Hong Yang, Cheng-Hai Zhang, Jia-Di Xing, Ming Cui, Xiang-Qian Su. Comparison of neoadjuvant chemotherapy followed by surgery vs. surgery alone for locally advanced gastric cancer: a meta-analysis. Chinese Medical Journal 2021; 134(14): 1669 doi: 10.1097/CM9.0000000000001603
|
18 |
Naveena A. N. Kumar, Anmi Jose, Nawaz Usman, Keshava Rajan, Murali Munisamy, Preethi S. Shetty, Mahadev Rao. Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges. Langenbeck's Archives of Surgery 2022; 407(1): 87 doi: 10.1007/s00423-021-02314-6
|
19 |
Yingsong Zheng, Yubo Ma, Chuhong Pang, KaiLai Yin, Kang Liu, Jinxia Chen, Mengli Zi, Yizhou Wei, Xiangdong Cheng, Li Yuan. A retrospective study: exploring the optimal patient population for adjuvant chemotherapy after D2 gastrectomy. Journal of Gastrointestinal Surgery 2024; 28(4): 365 doi: 10.1016/j.gassur.2024.01.021
|
20 |
Sabine Schiefer, Nerma Crnovrsanin, Eva Kalkum, Johannes A. Vey, Henrik Nienhüser, Ingmar F. Rompen, Georg M. Haag, Beat Müller-Stich, Franck Billmann, Thomas Schmidt, Pascal Probst, Rosa Klotz, Leila Sisic. Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas? A systematic review and meta-analysis. Frontiers in Surgery 2024; 11 doi: 10.3389/fsurg.2024.1382039
|
21 |
Mohammed Alradhi, Mohammed Safi, Shenghua Tao, Abdullah Al-danakh, Marwan Almoiliqy, Salem Baldi, Xiancheng Li. Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study. Therapeutic Advances in Urology 2022; 14 doi: 10.1177/17562872221079473
|
22 |
Yanan Chu, Fei Long, Xueliang Ding, Shaobo Tian. The effect of surgery and metastatic risk prediction in patients with gastrointestinal tract signet-ring cell carcinoma. Journal of Gastrointestinal Surgery 2024; 28(8): 1234 doi: 10.1016/j.gassur.2024.05.011
|
23 |
Mohammed Alradhi, Shuang Wen, Mohammed Safi, Abdullah Al‐danakh, Honglong Wang, Abdullah Shopit, Min Sun, Bo Fan, Xiancheng Li. Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation. Cancer Medicine 2023; 12(4): 3931 doi: 10.1002/cam4.5121
|
24 |
Ze-Feng Li, Zheng Li, Xiao-Jie Zhang, Chong-Yuan Sun, He Fei, Chun-Xia Du, Chun-Guang Guo, Dong-Bing Zhao. Perioperative chemotherapy improves survival of patients with locally advanced diffuse gastric cancer. World Journal of Gastrointestinal Surgery 2024; 16(9): 2878-2892 doi: 10.4240/wjgs.v16.i9.2878
Abstract(104) |
Core Tip(87) |
Full Article(HTML)(460)
|
Full Article with Cover (PDF)-9363K(17)
|
Audio-135K(0)
|
Peer-Review Report-169K(13)
|
Answering Reviewers-71K(11)
|
Supplementary Material-65K(11)
|
Full Article (PDF)-9011K(27)
|
Full Article (XML)-125K(12)
|
Times Cited (0)
|
Total Visits (1263)
|
Open
|
25 |
Ina Valeria Zurlo, Michele Basso, Antonia Strippoli, Maria Alessandra Calegari, Armando Orlandi, Alessandra Cassano, Mariantonietta Di Salvatore, Giovanna Garufi, Emilio Bria, Giampaolo Tortora, Carlo Barone, Carmelo Pozzo. Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren’s Classification in Pan–Cancer Analysis Era?. Cancers 2020; 12(7): 1749 doi: 10.3390/cancers12071749
|
26 |
Ying Guo, Qian Wang, Qing Tian, Changwen Bo, Na Li, Sujing Zhang, Peishun Li, Tao Huang. Clinicopathological Features and Prognostic-Related Risk Factors of Gastric Signet Ring Cell Carcinoma: A Meta-Analysis. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/3473445
|